Stocks
CSL LimitedCSLLY
OTCHealthcareBiotechnology$24.43-1.41%
An Australia-based biotechnology group specializing in plasma-derived therapies, recombinant proteins, and vaccines used to treat rare and serious diseases. Its core business, CSL Behring, manufactures immunoglobulins and other plasma therapies, while subsidiary Seqirus is a major global producer of...
Market Cap: $94.6B52W Range: $24.42 – $44.85
This page tracks all publicly disclosed congressional trades in CSL Limited (CSLLY), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 1 purchase and 2 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $50K – $100K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |